Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mind Medicine Mindmed Inc (NQ: MNMD ) 6.360 -0.060 (-0.93%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Mind Medicine Mindmed Inc < Previous 1 2 3 4 5 Next > MindMed Reports Second Quarter 2024 Financial Results and Business Updates August 13, 2024 From Mind Medicine Inc. Via Business Wire Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering August 09, 2024 From Mind Medicine (MindMed) Inc. Via Business Wire Mind Medicine (MindMed) Inc. Announces Proposed Public Offering August 09, 2024 From Mind Medicine (MindMed) Inc. Via Business Wire MindMed to Present at Canaccord Genuity’s 44th Annual Growth Conference August 06, 2024 From Mind Medicine Inc. Via Business Wire MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update August 06, 2024 From Mind Medicine Inc. Via Business Wire MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer July 29, 2024 From Mind Medicine Inc. Via Business Wire MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT) July 17, 2024 From Mind Medicine Inc. Via Business Wire MindMed to be Included in Russell 2000® and Russell 3000® Indexes June 28, 2024 From Mind Medicine Inc. Via Business Wire MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference June 21, 2024 From Mind Medicine Inc. Via Business Wire MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD) June 20, 2024 From Mind Medicine Via Business Wire MindMed to Participate in June Conferences May 28, 2024 From Mind Medicine Inc. Via Business Wire MindMed to Participate at May Investor Conferences May 09, 2024 From MindMed Via Business Wire New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US May 09, 2024 From Mind Medicine (MindMed) Inc. Via Business Wire MindMed Reports First Quarter 2024 Financial Results and Business Updates May 08, 2024 From MindMed Via Business Wire MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York May 04, 2024 From MindMed Via Business Wire MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update May 02, 2024 From MindMed Via Business Wire MindMed to Present at Upcoming May Medical Conferences April 25, 2024 From MindMed Via Business Wire MindMed to Present at Upcoming April Medical Conferences April 02, 2024 From Mind Medicine Via Business Wire MindMed Announces Voluntary Delisting from Cboe Canada April 01, 2024 From MindMed Via Business Wire The Next Great Biotech Boom Has Arrived March 19, 2024 EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END Via FinancialNewsMedia MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference March 11, 2024 From MindMed Via Business Wire Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement March 07, 2024 From Mind Medicine (MindMed) Inc. Via Business Wire MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder March 07, 2024 From Mind Medicine (MindMed) Inc. Via Business Wire MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120 March 01, 2024 From MindMed Via Business Wire MindMed Reports 2023 Financial Results and Business Updates February 28, 2024 From MindMed Via Business Wire MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update February 22, 2024 From MindMed Via Business Wire MindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences Conference February 07, 2024 From MindMed Via Business Wire MindMed Announces Business Update and Anticipated Milestones for 2024 January 08, 2024 From Mind Medicine (MindMed) Inc. Via Business Wire How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition January 24, 2024 EQNX::TICKER_START (NYSE:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(NASDAQ:ATAI) EQNX::TICKER_END Via FinancialNewsMedia Exposures Product Safety MindMed Announces Positive Topline Results from Phase 2b Trial of MM-120 in Generalized Anxiety Disorder December 14, 2023 From Mind Medicine Via Business Wire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.